Taiwan FDA registration ed9c371a06d24f695478d7a7cd70e34f
Aushi Ammycin 30 mcg paper ingots
TW: 傲世 安黴素30微克紙錠
Taiwan·Risk Class 2·OXOID LIMITED·Registered Mar 15, 2006 – Mar 15, 2011CancelledRegistration details
- Analysis ID
- ed9c371a06d24f695478d7a7cd70e34f
- Customs Code
- DHA00601615002
Company information
- Manufacturer
- OXOID LIMITED
- Manufacturer Country
- United Kingdom
- Authorized Representative
- Qixin Biotechnology Co., Ltd
Product details
- Intended Use
- It is used as an antibiotic susceptibility test for amphecline.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1620 抗菌感受性試驗盤
- Import Information
- import
Dates and status
- Registration Date
- Mar 15, 2006
- Expiry Date
- Mar 15, 2011
- Cancellation Date
- Nov 08, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Aushi Ammycin 30 mcg paper ingots in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ed9c371a06d24f695478d7a7cd70e34f and manufactured by OXOID LIMITED. The authorized representative in Taiwan is Qixin Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices